The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Regulatory News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SEC filings available on Company's web site

7 Jan 2014 16:54

RNS Number : 1212X
Akers Biosciences, Inc.
07 January 2014
 



 

8 January 2014

 

Akers Biosciences, Inc.

("ABI" or the "Company")

 

SEC filings available on Company's web site

 

Akers Biosciences, Inc. (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that, further to its previous announcements regarding the proposed listing of the Company's common shares (the "Securities") on The NASDAQ Capital Market ("NASDAQ") and the concurrent registered public offering (the "Offering"), all the amendments to the Company's S-1 filing are available on the Company's web site (at http://ir.akersbiosciences.com/sec.cfm) together with the Free Writing Prospectus (FWP), or presentation, which has been filed with the SEC and will be used during the marketing process.

 

The Offering is subject to market and other conditions, and there can be no assurances as to whether or when the Offering may be completed or as to the actual size or terms of the Offering. A registration statement relating to these Securities has been filed with the SEC but has not yet become effective. These Securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these Securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the Securities laws of any such state or jurisdiction.

 

- ends -

 

Enquiries:

Thomas A. Nicolette, President and CEO

Tel. +1 856 848 8698

Antony Legge / James Thomas

Daniel Stewart (Nomad and Broker)

 

Tel. +44 (0)20 7776 6550

 

 

About Akers Biosciences, Inc.

Akers Biosciences develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring healthcare information both rapidly and directly to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. ABI has aligned with major healthcare companies and high volume medical products distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics. Additional information on the Company and its products can be found at www.akersbiosciences.com

 

About Chubeworkx / en10 Global Limited

Combining leading science innovations and clever design, en10, an indirect subsidiary of Chubeworkx, provides people the means to effect simple, precise, low-cost alcohol screening and programmes and products to encourage broader, positive changes in attitudes to responsible alcohol consumption. It provides a fresh approach to achieving a healthy work culture and a more productive business: cutting costs and improving lives. Additional information on the company and its products can be found at www.en-10.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRBRMFTMBIMBLI
Date   Source Headline
4th Jun 20147:00 amRNSDistribution Agreement Signed
16th May 20147:00 amRNSAgreement to Market Rapid Tests in India
14th May 201412:00 pmRNSFirst Quarter Results
7th May 20147:00 amRNSInternational Distribution Agreement
30th Apr 20147:01 amRNSClinical Trials for PIFA PLUSS Chlamydia Assay
28th Mar 201411:00 amRNSFinal Results
27th Mar 201411:00 amRNSSenior Managerial Appointment
12th Mar 20145:12 pmRNSDirectorate Change
11th Mar 20144:30 pmRNSNASDAQ IPO Update
11th Mar 20144:29 pmRNSHolding(s) in Company
31st Jan 20145:30 pmRNSHolding(s) in Company
31st Jan 20147:00 amRNSDirector/PDMR Shareholding
31st Jan 20147:00 amRNSTotal Voting Rights
27th Jan 20142:46 pmRNSAppointment of Non-Executive Director
24th Jan 20147:30 amRNSRestoration - Akers Biosciences, Inc
23rd Jan 20146:10 pmRNSPricing of Offering & Recommencement of Trading
23rd Jan 20147:30 amRNSSuspension - Akers Biosciences, Inc.
23rd Jan 20147:30 amRNSTemporary Suspension
7th Jan 20145:27 pmRNSCorrection: SEC filings available on website
7th Jan 20144:54 pmRNSSEC filings available on Company's web site
2nd Jan 201410:37 amRNSHolding(s) in Company
31st Dec 201312:34 pmRNSCorrection: Total Voting Rights
31st Dec 20138:00 amRNSTotal Voting Rights
30th Dec 20137:00 amRNSIssue of Equity
23rd Dec 20137:00 amRNSPlacing of Shares
9th Dec 20137:00 amRNSProposed NASDAQ Listing
6th Dec 20137:00 amRNSDirector Dealing
5th Dec 20139:51 amRNSHolding(s) in Company
29th Nov 20134:00 pmRNSTotal Voting Rights
18th Nov 20137:00 amRNSShare Capital Consolidation
15th Nov 20132:37 pmRNSUnaudited results for nine months ended 30.09.2013
7th Nov 20134:55 pmRNSHolding(s) in Company
23rd Oct 20133:09 pmRNSHolding(s) in Company
17th Oct 20132:09 pmRNSHolding(s) in Company
17th Oct 20131:54 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results for Six Months Ended 30 June 2013
15th Aug 20138:55 amRNSHolding(s) in Company
8th Aug 20137:00 amRNSProposed NASDAQ Listing
23rd Jul 20137:00 amRNSDirector's Dealing
19th Jul 20137:00 amRNSTrading Statement
10th Jul 20139:51 amRNSHolding(s) in Company
1st Jul 20139:41 amRNSAppointment of Non-Executive Directors
26th Jun 20137:00 amRNSPreliminary Results for Year End 31 December 2012
14th Jun 201312:25 pmRNSHolding(s) in Company
13th Jun 20131:24 pmRNSExtension of Agreement & $1.6m Subscription
10th Apr 20137:00 amRNSTrading Update
27th Feb 20138:39 amRNSFinal Award of NF Mark
19th Feb 20137:00 amRNSTrading Update
20th Dec 20125:35 pmRNSResult of AGM
11th Dec 20127:00 amRNS3.5m unit Order for Breath Alcohol tubes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.